Department of Gastroenterology, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, China.
Center for Advanced Endoscopy, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
Lancet Gastroenterol Hepatol. 2020 Apr;5(4):343-351. doi: 10.1016/S2468-1253(19)30411-X. Epub 2020 Jan 22.
BACKGROUND: Colonoscopy with computer-aided detection (CADe) has been shown in non-blinded trials to improve detection of colon polyps and adenomas by providing visual alarms during the procedure. We aimed to assess the effectiveness of a CADe system that avoids potential operational bias. METHODS: We did a double-blind randomised trial at the endoscopy centre in Caotang branch hospital of Sichuan Provincial People's Hospital in China. We enrolled consecutive patients (aged 18-75 years) presenting for diagnostic and screening colonoscopy. We excluded patients with a history of inflammatory bowel disease, colorectal cancer, or colorectal surgery or who had a contraindication for biopsy; we also excluded patients who had previously had an unsuccessful colonoscopy and who had a high suspicion for polyposis syndromes, inflammatory bowel disease, and colorectal cancer. We allocated patients (1:1) to colonoscopy with either the CADe system or a sham system. Randomisation was by computer-generated random number allocation. Patients and the endoscopist were unaware of the random assignment. To achieve masking, the output of the system was shown on a second monitor that was only visible to an observer who was responsible for reporting the alerts. The primary outcome was the adenoma detection rate (ADR), which is the proportion of individuals having a complete colonoscopy, from caecum to rectum, who had one or more adenomas detected. The primary analysis was per protocol. We also analysed characteristics of polyps and adenomas missed initially by endoscopists but detected by the CADe system. This trial is complete and is registered with http://www.chictr.org.cn, ChiCTR1800017675. FINDINGS: Between Sept 3, 2018, and Jan 11, 2019, 1046 patients were enrolled to the study, of whom 36 were excluded before randomisation, 508 were allocated colonoscopy with polyp detection using the CADe system, and 502 were allocated colonoscopy with the sham system. After further excluding patients who met exclusion criteria, 484 patients in the CADe group and 478 in the sham group were included in analyses. The ADR was significantly greater in the CADe group than in the sham group, with 165 (34%) of 484 patients allocated to the CADe system having one or more adenomas detected versus 132 (28%) of 478 allocated to the sham system (odds ratio 1·36, 95% CI 1·03-1·79; p=0·030). No complications were reported among all colonoscopy procedures. Polyps initially missed by the endoscopist but identified by the CADe system were generally small in size, isochromatic, flat in shape, had an unclear boundary, were partly behind colon folds, and were on the edge of the visual field. INTERPRETATION: Polyps initially missed by the endoscopist had characteristics that are sometimes difficult for skilled endoscopists to recognise. Such polyps could be detected using a high-performance CADe system during colonoscopy. The effect of CADe during colonoscopy on the incidence of interval colorectal cancer should be investigated. FUNDING: None.
背景:计算机辅助检测(CADe)的结肠镜检查已在非盲试验中显示,通过在手术过程中提供视觉警报,可提高结肠息肉和腺瘤的检测率。我们旨在评估一种避免潜在操作偏差的 CADe 系统的有效性。
方法:我们在中国四川省人民医院草堂分院的内镜中心进行了一项双盲随机试验。我们纳入了接受诊断性和筛查性结肠镜检查的连续患者(年龄 18-75 岁)。我们排除了有炎症性肠病、结直肠癌或结直肠手术病史或有活检禁忌证的患者;我们还排除了先前结肠镜检查不成功且怀疑有息肉病综合征、炎症性肠病和结直肠癌的患者。我们以 1:1 的比例将患者分配到接受 CADe 系统或模拟系统的结肠镜检查。随机化是通过计算机生成的随机数分配进行的。患者和内镜医生都不知道随机分组。为了实现掩蔽,系统的输出显示在第二个监视器上,只有负责报告警报的观察者才能看到该监视器。主要结局是腺瘤检出率(ADR),即接受完整结肠镜检查(从盲肠到直肠)的个体中,有一个或多个腺瘤被检出的比例。主要分析是基于方案。我们还分析了最初被内镜医生遗漏但被 CADe 系统检测到的息肉和腺瘤的特征。该试验已完成,并在 http://www.chictr.org.cn 上注册,注册号 ChiCTR1800017675。
结果:2018 年 9 月 3 日至 2019 年 1 月 11 日期间,共有 1046 名患者入组该研究,其中 36 名患者在随机分组前被排除,508 名患者接受 CADe 系统检测的息肉检测,502 名患者接受模拟系统检测的息肉检测。在进一步排除符合排除标准的患者后,CADe 组有 484 名患者和模拟组有 478 名患者纳入分析。CADe 组的 ADR 明显高于模拟组,CADe 组 484 名患者中有 165 名(34%)检测到一个或多个腺瘤,而模拟组 478 名患者中有 132 名(28%)(比值比 1.36,95%CI 1.03-1.79;p=0.030)。所有结肠镜检查过程中均未报告并发症。最初被内镜医生遗漏但被 CADe 系统识别的息肉通常体积较小、同色、扁平状、边界不清、部分位于结肠褶皱后面,且位于视野边缘。
解释:最初被内镜医生遗漏的息肉具有一些特征,有时经验丰富的内镜医生难以识别。在结肠镜检查过程中使用高性能的 CADe 系统可以检测到这些息肉。CADe 在结肠镜检查中对结直肠癌间隔期发生率的影响应进行调查。
经费:无。
Lancet Gastroenterol Hepatol. 2020-1-22
Lancet Gastroenterol Hepatol. 2020-1-22
Gastroenterology. 2020-8
Cancers (Basel). 2025-3-22
Cancers (Basel). 2025-2-16
Therap Adv Gastroenterol. 2025-1-31